These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 23100567

  • 1. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.
    J Infect Dis; 2013 Jan 01; 207(1):72-9. PubMed ID: 23100567
    [Abstract] [Full Text] [Related]

  • 2. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.
    Thierfelder C, Weber R, Elzi L, Furrer H, Cavassini M, Calmy A, Bernasconi E, Gutmann C, Ledergerber B, Swiss HIV Cohort Study Group.
    HIV Med; 2012 Feb 01; 13(2):118-26. PubMed ID: 22107170
    [Abstract] [Full Text] [Related]

  • 3. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G, Lewden C, Spire B, Salmon D, Brun-Vézinet F, Duong M, Allavena C, Leport C, Salamon R, APROCO COPILOTE ANRS CO8 Study Group.
    HIV Med; 2007 Apr 01; 8(3):164-70. PubMed ID: 17461860
    [Abstract] [Full Text] [Related]

  • 4. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries.
    Greig J, Casas EC, O'Brien DP, Mills EJ, Ford N.
    AIDS; 2012 Jul 31; 26 Suppl 1():S31-7. PubMed ID: 22781173
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes.
    Zürcher K, Mooser A, Anderegg N, Tymejczyk O, Couvillon MJ, Nash D, Egger M, IeDEA and MESH consortia.
    Trop Med Int Health; 2017 Apr 31; 22(4):375-387. PubMed ID: 28102610
    [Abstract] [Full Text] [Related]

  • 6. [Survival and immune response of rural HIV/AIDS patients after free antiretroviral therapy].
    Ding YY, Jia WQ, Wang JS, Dong SL, Yang QH, Zhou RY, Qu SX, Lu LX, Wei J, Qiao XC, Gao MY, Guo XL, Zhang TJ, Wu ZY, He N.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec 31; 29(12):1176-80. PubMed ID: 19173958
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
    Seyler C, Anglaret X, Dakoury-Dogbo N, Messou E, Touré S, Danel C, Diakité N, Daudié A, Inwoley A, Maurice C, Tonwe-Gold B, Rouet F, N'Dri-Yoman T, Salamon R, ANRS 1203 Study Group.
    Antivir Ther; 2003 Oct 31; 8(5):385-93. PubMed ID: 14640385
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR, Pediatric AIDS Clinical Trials Group 219/219C Study Team.
    Clin Infect Dis; 2008 Feb 15; 46(4):507-15. PubMed ID: 18199042
    [Abstract] [Full Text] [Related]

  • 13. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve EN, Kayabu D, Nassari NO, Todd J.
    Trop Med Int Health; 2015 Jun 15; 20(6):791-6. PubMed ID: 25706518
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
    Farahani M, Vable A, Lebelonyane R, Seipone K, Anderson M, Avalos A, Chadborn T, Tilahun H, Roumis D, Moeti T, Musuka G, Busang L, Gaolathe T, Malefho KC, Marlink R.
    Lancet Glob Health; 2014 Jan 15; 2(1):e44-50. PubMed ID: 25104635
    [Abstract] [Full Text] [Related]

  • 15. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.
    Nachega JB, Mutamba B, Basangwa D, Nguyen H, Dowdy DW, Mills EJ, Katabira E, Nakimuli-Mpungu E.
    Trop Med Int Health; 2013 Jan 15; 18(1):53-7. PubMed ID: 23136882
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
    Lohse N, Kronborg G, Gerstoft J, Larsen CS, Pedersen G, Pedersen C, Sørensen HT, Obel N.
    Clin Infect Dis; 2006 Jan 01; 42(1):136-44. PubMed ID: 16323104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.